Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 147353-95-5 | MDL No. : | MFCD24387088 |
Formula : | C13H18ClNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QUURCBFBLHSKLE-UHFFFAOYSA-N |
M.W : | 271.74 | Pubchem ID : | 19968645 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.46 |
Num. rotatable bonds : | 6 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 70.94 |
TPSA : | 58.56 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.25 cm/s |
Log Po/w (iLOGP) : | 2.73 |
Log Po/w (XLOGP3) : | 2.4 |
Log Po/w (WLOGP) : | 2.57 |
Log Po/w (MLOGP) : | 2.34 |
Log Po/w (SILICOS-IT) : | 2.33 |
Consensus Log Po/w : | 2.47 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.89 |
Solubility : | 0.352 mg/ml ; 0.0013 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.27 |
Solubility : | 0.145 mg/ml ; 0.000535 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.84 |
Solubility : | 0.039 mg/ml ; 0.000144 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.57 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With triethylamine In tetrahydrofuran at 20℃; | Step 1: (rac)-tert-butyl (1 -(4-chlorophenyl)-2-hydroxyethyl)carbamate:To a solution of (rac)-2-amino-2-(4-chlorophenyl)ethanol (2 g, 1 1 .65 mmol) (prepared as described WO2009/47563 A1 ) in THF (20 ml) was added Boc anhydride (2.84 ml, 12.24 mmol) followed by triethylamine (2.436 ml, 17.48 mmol) . The reaction mixture was then stirred at RT and maintained at this temperature overnight. The reaction mixture was concentrated in vacuo, diluted with EtOAc and 1 N HCI and extracted. The organic extracts were then washed with brine, dried (Na2S04) and concentrated in vacuo affording the title compound as a sticky solid (2.8 g, 88percent). 1H NMR (500 MHz, CDCI3): 7.34 (2H, m), 7.27 (1 H, d), 5.35 (1 H, m), 4.75 (1 H, m), 3.75- 3.90 (2H, m), 1 .44 (9H, s). |
14% | With triethylamine In methanol; ethyl acetate at 20℃; for 2 h; | The remainder of the solution was treated with triethylamine (18.02 mL, 129.31 mmol) and di-tert-butyl dicarbonate (14.11 g, 64.65 mmol). The mixture was stirred for 2 hours at room temperature before being partitioned between ethyl acetate and water. The organic layer was dried with magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by MPLC on silica using gradient elution (10percent ethyl acetate / DCM to 50percent ethyl acetate / DCM). The desired product, tert-butyl l-(4- chlorophenyl)-2-hydroxyethylcarbamate (7.91 g, 45.0 percent), was thus isolated as a colourless solid. Impure fractions were repurified by MPLC to give a second crop (2.4 Ig, 14percent). IH NMR (399.9 MHz, DMSO-d6) δ 1.37 (9H, s), 3.41 - 3.52 (2H, m), 4.42 - 4.58 (IH, m), 4.79 (IH, t), 7.23 (IH, d), 7.31 (2H, d), 7.37 (2H, d). |
[ 926291-64-7 ]
(R)-tert-Butyl (1-(3-chlorophenyl)-2-hydroxyethyl)carbamate
Similarity: 0.99
[ 67341-01-9 ]
tert-Butyl (2-hydroxy-1-phenylethyl)carbamate
Similarity: 0.84
[ 769944-39-0 ]
tert-Butyl 2-(4-chlorophenyl)piperazine-1-carboxylate
Similarity: 0.83
[ 886767-49-3 ]
tert-Butyl 3-(4-chlorophenyl)piperazine-1-carboxylate
Similarity: 0.83
[ 926291-64-7 ]
(R)-tert-Butyl (1-(3-chlorophenyl)-2-hydroxyethyl)carbamate
Similarity: 0.99
[ 769944-39-0 ]
tert-Butyl 2-(4-chlorophenyl)piperazine-1-carboxylate
Similarity: 0.83
[ 886767-49-3 ]
tert-Butyl 3-(4-chlorophenyl)piperazine-1-carboxylate
Similarity: 0.83
[ 1799438-97-3 ]
(R)-tert-Butyl (1-(2-bromo-4-chlorophenyl)ethyl)carbamate
Similarity: 0.76
[ 926291-64-7 ]
(R)-tert-Butyl (1-(3-chlorophenyl)-2-hydroxyethyl)carbamate
Similarity: 0.99
[ 67341-01-9 ]
tert-Butyl (2-hydroxy-1-phenylethyl)carbamate
Similarity: 0.84
[ 718611-17-7 ]
(S)-Boc-3-Amino-3-phenylpropan-1-ol
Similarity: 0.77
[ 158807-47-7 ]
(R)-N-Boc-3-Amino-3-phenylpropan-1-ol
Similarity: 0.77
[ 1426129-50-1 ]
(R)-tert-Butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate
Similarity: 0.75
[ 926291-64-7 ]
(R)-tert-Butyl (1-(3-chlorophenyl)-2-hydroxyethyl)carbamate
Similarity: 0.99
[ 67341-01-9 ]
tert-Butyl (2-hydroxy-1-phenylethyl)carbamate
Similarity: 0.84
[ 769944-39-0 ]
tert-Butyl 2-(4-chlorophenyl)piperazine-1-carboxylate
Similarity: 0.83
[ 886767-49-3 ]
tert-Butyl 3-(4-chlorophenyl)piperazine-1-carboxylate
Similarity: 0.83
[ 926291-64-7 ]
(R)-tert-Butyl (1-(3-chlorophenyl)-2-hydroxyethyl)carbamate
Similarity: 0.99
[ 67341-01-9 ]
tert-Butyl (2-hydroxy-1-phenylethyl)carbamate
Similarity: 0.84
[ 718611-17-7 ]
(S)-Boc-3-Amino-3-phenylpropan-1-ol
Similarity: 0.77
[ 158807-47-7 ]
(R)-N-Boc-3-Amino-3-phenylpropan-1-ol
Similarity: 0.77